
### [MONDO:0018118](http://purl.obolibrary.org/obo/MONDO_0018118)
**Label:** disorder of phospholipids, sphingolipids and fatty acids biosynthesis with central nervous system predominant involvement

**Subclasses:** [MONDO:0013760](http://purl.obolibrary.org/obo/MONDO_0013760) (congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome), [MONDO:0014464](http://purl.obolibrary.org/obo/MONDO_0014464) (progressive encephalopathy with leukodystrophy due to DECR deficiency), [MONDO:0017998](http://purl.obolibrary.org/obo/MONDO_0017998) (PLA2G6-associated neurodegeneration), [MONDO:0016304](http://purl.obolibrary.org/obo/MONDO_0016304) (classic pantothenate kinase-associated neurodegeneration), [MONDO:0012189](http://purl.obolibrary.org/obo/MONDO_0012189) (Amish infantile epilepsy syndrome), [MONDO:0010031](http://purl.obolibrary.org/obo/MONDO_0010031) (Sjogren-Larsson syndrome), [MONDO:0018275](http://purl.obolibrary.org/obo/MONDO_0018275) (salt and pepper syndrome), [MONDO:0013060](http://purl.obolibrary.org/obo/MONDO_0013060) (autosomal recessive Parkinson disease 14), [MONDO:0018274](http://purl.obolibrary.org/obo/MONDO_0018274) (GM3 synthase deficiency), [MONDO:0009319](http://purl.obolibrary.org/obo/MONDO_0009319) (pantothenate kinase-associated neurodegeneration), [MONDO:0009739](http://purl.obolibrary.org/obo/MONDO_0009739) (neurodegeneration with brain iron accumulation 2a), [MONDO:0014417](http://purl.obolibrary.org/obo/MONDO_0014417) (spinocerebellar ataxia type 38), [MONDO:0012787](http://purl.obolibrary.org/obo/MONDO_0012787) (hereditary spastic paraplegia 39), [MONDO:0012444](http://purl.obolibrary.org/obo/MONDO_0012444) (neurodegeneration with brain iron accumulation 2b), [MONDO:0014545](http://purl.obolibrary.org/obo/MONDO_0014545) (progressive myoclonic epilepsy type 8), [MONDO:0013875](http://purl.obolibrary.org/obo/MONDO_0013875) (3-methylglutaconic aciduria with deafness, encephalopathy, and Leigh-like syndrome), [MONDO:0016305](http://purl.obolibrary.org/obo/MONDO_0016305) (atypical pantothenate kinase-associated neurodegeneration), [MONDO:0017999](http://purl.obolibrary.org/obo/MONDO_0017999) (fatty acid hydroxylase-associated neurodegeneration), 

**Corr. equiv. classes:** [Orphanet:370933](http://www.orpha.net/ORDO/Orphanet_370933), [Orphanet:424027](http://www.orpha.net/ORDO/Orphanet_424027), [Orphanet:370938](http://www.orpha.net/ORDO/Orphanet_370938), [Orphanet:329308](http://www.orpha.net/ORDO/Orphanet_329308), [Orphanet:139480](http://www.orpha.net/ORDO/Orphanet_139480), [Orphanet:216866](http://www.orpha.net/ORDO/Orphanet_216866), [OMIM:616034](http://purl.obolibrary.org/obo/OMIM_616034), [Orphanet:329303](http://www.orpha.net/ORDO/Orphanet_329303), [OMIM:616230](http://purl.obolibrary.org/obo/OMIM_616230), [Orphanet:352333](http://www.orpha.net/ORDO/Orphanet_352333), [OMIM:256600](http://purl.obolibrary.org/obo/OMIM_256600), [Orphanet:816](http://www.orpha.net/ORDO/Orphanet_816), [OMIM:614457](http://purl.obolibrary.org/obo/OMIM_614457), [OMIM:612953](http://purl.obolibrary.org/obo/OMIM_612953), [OMIM:610217](http://purl.obolibrary.org/obo/OMIM_610217), [OMIM:609056](http://purl.obolibrary.org/obo/OMIM_609056), [OMIM:614739](http://purl.obolibrary.org/obo/OMIM_614739), [Orphanet:423296](http://www.orpha.net/ORDO/Orphanet_423296), [Orphanet:199351](http://www.orpha.net/ORDO/Orphanet_199351), [Orphanet:216873](http://www.orpha.net/ORDO/Orphanet_216873), [Orphanet:157850](http://www.orpha.net/ORDO/Orphanet_157850), [Orphanet:431361](http://www.orpha.net/ORDO/Orphanet_431361), [OMIM:612020](http://purl.obolibrary.org/obo/OMIM_612020), [Orphanet:171714](http://www.orpha.net/ORDO/Orphanet_171714), [Orphanet:352328](http://www.orpha.net/ORDO/Orphanet_352328), [Orphanet:35069](http://www.orpha.net/ORDO/Orphanet_35069), [OMIM:615957](http://purl.obolibrary.org/obo/OMIM_615957), [OMIM:234200](http://purl.obolibrary.org/obo/OMIM_234200), [OMIM:270200](http://purl.obolibrary.org/obo/OMIM_270200), 

**Class expressions from DL-Learner:**

- [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 28.71%
- [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 28.50%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 27.84%
- Thing 27.83%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 27.83%
- [HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature) 23.78%
- [HP:0003808](http://purl.obolibrary.org/obo/HP_0003808) (Abnormal muscle tone) 22.86%
- [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 22.32%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) 22.27%
- [HP:0001257](http://purl.obolibrary.org/obo/HP_0001257) (Spasticity) 21.76%
- [HP:0000478](http://purl.obolibrary.org/obo/HP_0000478) (Abnormality of the eye) 21.64%
- [HP:0001276](http://purl.obolibrary.org/obo/HP_0001276) (Hypertonia) 21.13%
- [HP:0001507](http://purl.obolibrary.org/obo/HP_0001507) (Growth abnormality) 16.44%
- [HP:0000152](http://purl.obolibrary.org/obo/HP_0000152) (Abnormality of head or neck) 15.91%
- [HP:0000924](http://purl.obolibrary.org/obo/HP_0000924) (Abnormality of the skeletal system) 15.85%


